RECRUITING

Virtual 1-Session Spanish "Empowered Relief" Group Intervention for Chronic Pain

Conditions

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

Empowered Relief (ER) is a 1-session pain relief skills intervention that is delivered in-person or online by certified clinicians to groups of patients with acute or chronic pain. Prior work in has shown ER efficacy for reducing chronic pain, pain-related distress, and other symptoms 6 months post-treatment. The purpose of this randomized trial is to conduct the first feasibility and early efficacy test of online Spanish ER delivered to Spanish-speaking adult patients with chronic pain. Participants will be followed for 1 month via 3 follow-up surveys (immediately after treatment, 2 weeks and 1 month post-treatment).

Official Title

Efficacy of a 1-Session Spanish "Empowered Relief" Videoconference-Delivered Group Intervention for Chronic Pain

Quick Facts

Study Start:2024-06-12
Study Completion:2025-12-31
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT04546685

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. 1. Age 18+
  2. 2. Chronic pain (at least 3 months or more)
  3. 3. Spanish fluency
  4. 4. Ability to adhere to and complete study procedures
  1. 1. Cognitive impairment
  2. 2. Previous participation in the Empowered Relief class

Contacts and Locations

Study Contact

Lorena Contreras
CONTACT
650-497-6141
spanishempoweredrelief@stanford.edu
Corrine A Jung, PhD
CONTACT
cejung@stanford.edu

Principal Investigator

Beth Darnall, PhD
PRINCIPAL_INVESTIGATOR
Stanford University

Study Locations (Sites)

1070 Arastradero Rd
Palo Alto, California, 94304-1334
United States

Collaborators and Investigators

Sponsor: Stanford University

  • Beth Darnall, PhD, PRINCIPAL_INVESTIGATOR, Stanford University

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-06-12
Study Completion Date2025-12-31

Study Record Updates

Study Start Date2024-06-12
Study Completion Date2025-12-31

Terms related to this study

Additional Relevant MeSH Terms

  • Chronic Pain